TAK
Takeda Pharmaceutical Co Ltd ADR
NYSE: TAK · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$16.68
+2.33% today
Updated 2026-04-30
Market cap
$52.54B
P/E ratio
75.59
P/S ratio
0.01x
EPS (TTM)
$0.22
Dividend yield
3.98%
52W range
$13 – $19
Volume
2.8M
WallStSmart proprietary scores
60
out of 100
Grade: C+
Hold
Investment rating
6.7
Growth
B5.0
Quality
C+4.5
Profitability
C5.7
Valuation
C+—/9
Piotroski F-Score
—
—
Altman Z-Score
—
—
Industry rank
—
View all highly rated stocks (75+) →201 stocks currently score above 75
Price targets
Analyst target
$20.45
+22.60%
12-Month target
$10.30
-38.25%
Intrinsic (DCF)
—
Margin of safety
—
0 Strong Buy3 Buy0 Hold0 Sell0 Strong Sell
Price chart
X-Ray snapshot
Strengths
+ Free cash flow $317.47B — positive
Risks
- Thin margins at 2.53%
- P/E 75.59x — expensive valuation
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM | 2026 (E) |
|---|---|---|---|---|---|---|
| Revenue | $3.57T | $4.03T | $4.26T | $4.58T | $4.46T | $4630.0B |
| Net income | $230.06B | $317.02B | $144.07B | $107.93B | $105.51B | — |
| EPS | — | — | — | — | $0.22 | $119.00 |
| Free cash flow | $937.07B | $343.47B | $235.61B | $856.39B | $317.47B | — |
| Profit margin | 6.45% | 7.87% | 3.38% | 2.36% | 2.53% | — |
Peer comparison
Smart narrative
Takeda Pharmaceutical Co Ltd ADR trades at $16.68. representing a P/E of 75.59x trailing earnings. Our Smart Value Score of 60/100 indicates the stock is good. TTM revenue stands at $4.46T. with profit margins at 2.53%.
Frequently asked questions
What is Takeda Pharmaceutical Co Ltd ADR's stock price?
Takeda Pharmaceutical Co Ltd ADR (TAK) trades at $16.68.
Is Takeda Pharmaceutical Co Ltd ADR overvalued?
Smart Value Score 60/100 (Grade C+, Hold).
What is the price target of Takeda Pharmaceutical Co Ltd ADR (TAK)?
The analyst target price is $20.45, representing +22.6% upside from the current price of $16.68.
What is the future stock price of TAK by 2030?
Our research-backed model estimates Takeda Pharmaceutical Co Ltd ADR could reach $22,373.69 by 2030, based on analyst consensus, management guidance, and sector analysis.
What is Takeda Pharmaceutical Co Ltd ADR's revenue?
TTM revenue is $4.46T.
Company info
SectorHEALTHCARE
IndustryDRUG MANUFACTURERS - SPECIALTY & GENERIC
CountryUSA
ExchangeNYSE
CurrencyUSD
Quick metrics
P/S ratio0.01x
ROE1.50%
Beta0.13
50D MA$18.10
200D MA$15.74
Shares out3.16B
Float1.58B
Short ratio—
Avg volume2.8M
Performance
1 week-2.10%
1 month-11.99%
3 months-5.07%
YTD+4.55%
1 year—
3 years—
5 years—